Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 354084, 11 pages
http://dx.doi.org/10.1155/2015/354084
Research Article

Incidence and Diversity of Antimicrobial Multidrug Resistance Profiles of Uropathogenic Bacteria

1Department of Biology and CESAM, University of Aveiro, 3810-193 Aveiro, Portugal
2Clinical Analysis Laboratory Avelab, Rua Cerâmica do Vouga, 3800-011 Aveiro, Portugal

Received 15 January 2015; Accepted 23 February 2015

Academic Editor: Frederick D. Quinn

Copyright © 2015 Inês Linhares et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Grabe, T. E. Bjerklund-Johansen, H. Botto et al., Guidelines on Urological Infections, European Association of Urology, 2013.
  2. M. Alzohairy and H. Khadri, “Frequency and antibiotic susceptibility pattern of uro-pathogens isolated from community and hospital-acquired infections in saudi arabia—a prospective case study,” British Journal of Medicine & Medical Research, vol. 1, no. 2, pp. 45–56, 2011. View at Publisher · View at Google Scholar
  3. P. Baral, S. Neupane, B. P. Marasini, K. R. Ghimire, B. Lekhak, and B. Shrestha, “High prevalence of multidrug resistance in bacterial uropathogens from Kathmandu, Nepal,” BMC Research Notes, vol. 5, article 38, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Y. Furuya and F. D. Lowy, “Antimicrobial-resistant bacteria in the community setting,” Nature Reviews Microbiology, vol. 4, no. 1, pp. 36–45, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Poole, “Efflux-mediated antimicrobial resistance,” The Journal of Antimicrobial Chemotherapy, vol. 56, no. 1, pp. 20–51, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. D. G. White and P. F. McDermott, “Biocides, drug resistance and microbial evolution,” Current Opinion in Microbiology, vol. 4, no. 3, pp. 313–317, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. J. S. Chapman, “Disinfectant resistance mechanisms, cross-resistance, and co-resistance,” International Biodeterioration and Biodegradation, vol. 51, no. 4, pp. 271–276, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Poole, “Acquired resistance,” in Acquired Resistance, A. P. L. P. Fraise and J.-Y. Maillard, Eds., pp. 170–183, Blackwell Scientific Publication, Oxford, UK, 4th edition, 2004. View at Google Scholar
  9. D. Kücken, H.-H. Feucht, and P.-M. Kaulfers, “Association of qacE and qacEΔ1 with multiple resistance to antibiotics and antiseptics in clinical isolates of Gram-negative bacteria,” FEMS Microbiology Letters, vol. 183, no. 1, pp. 95–98, 2000. View at Google Scholar · View at Scopus
  10. M. Grabe, M. C. Bishop, T. E. Bjerklund-Johansen et al., “Guidelines on urological infections,” in European Association of Urology, 2009. View at Google Scholar
  11. I. Linhares, T. Raposo, A. Rodrigues, and A. Almeida, “Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000–2009),” BMC Infectious Diseases, vol. 13, article 19, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. Clinical and Laboratory Standard Institute (CLSI), Performance Standards for Antimicrobial Susceptibility Testing, CLSI, Wayne, Pa, USA, 2010.
  13. A.-P. Magiorakos, A. Srinivasan, R. B. Carey et al., “Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance,” Clinical Microbiology and Infection, vol. 18, no. 3, pp. 268–281, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. J. A. Karlowsky, D. J. Hoban, M. R. Decorby, N. M. Laing, and G. G. Zhanel, “Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance Study,” Antimicrobial Agents and Chemotherapy, vol. 50, no. 6, pp. 2251–2254, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. W. E. van der Starre, C. van Nieuwkoop, S. Paltansing et al., “Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection,” The Journal of Antimicrobial Chemotherapy, vol. 66, no. 3, Article ID dkq465, pp. 650–656, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Adriaenssens, S. Coenen, A. Versporten et al., “European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997–2009),” The Journal of Antimicrobial Chemotherapy, vol. 66, supplement 6, pp. vi3–vi12, 2011. View at Google Scholar
  17. I. Ramalhinho, M. Ribeirinho, I. Vieira, and J. Cabrita, “A Evolução do Consumo de Antibióticos em Ambulatório em Portugal Continental 2000–2009,” Acta Médica Portuguesa, vol. 25, pp. 20–28, 2012. View at Google Scholar · View at Scopus
  18. D. L. Paterson and R. A. Bonomo, “Extended-spectrum β-lactamases: a clinical update,” Clinical Microbiology Reviews, vol. 18, no. 4, pp. 657–686, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Seppälä, T. Klaukka, J. Vuopio-Varkila et al., “The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group a streptococci in Finland,” The New England Journal of Medicine, vol. 337, no. 7, pp. 441–446, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. D. J. Austin, K. G. Kristinsson, and R. M. Anderson, “The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 3, pp. 1152–1156, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. V. I. Enne, D. M. Livermore, P. Stephens, and L. M. C. Hall, “Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction,” The Lancet, vol. 357, no. 9265, pp. 1325–1328, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. B. S. Gottesman, Y. Carmeli, P. Shitrit, and M. Chowers, “Impact of quinolone restriction on resistance patterns of Escherichia coli isolated from urine by culture in a community setting,” Clinical Infectious Diseases, vol. 49, no. 6, pp. 869–875, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Lipsitch, “The rise and fall of antimicrobial resistance,” Trends in Microbiology, vol. 9, no. 9, pp. 438–444, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. M. J. Zervos, E. Hershberger, D. P. Nicolau et al., “Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991–2000,” Clinical Infectious Diseases, vol. 37, no. 12, pp. 1643–1648, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Mokracka, R. Koczura, K. PawŁowski, and A. Kaznowski, “Resistance patterns and integron cassette arrays of enterobacter cloacae complex strains of human origin,” Journal of Medical Microbiology, vol. 60, no. 6, pp. 737–743, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Collignon, J. H. Powers, T. M. Chiller, A. Aidara-Kane, and F. M. Aarestrup, “World Health Organization ranking of antimicrobials according to their importance in human medicine: a critical step for developing risk management strategies for the use of antimicrobials in food production animals,” Clinical Infectious Diseases, vol. 49, no. 1, pp. 132–141, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. G. A. Jacoby, “AmpC β-lactamases,” Clinical Microbiology Reviews, vol. 22, no. 1, pp. 161–182, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. J. D. D. Pitout, P. Nordmann, K. B. Laupland, and L. Poirel, “Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community,” The Journal of Antimicrobial Chemotherapy, vol. 56, no. 1, pp. 52–59, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Dalhoff, “Global fluoroquinolone resistance epidemiology and implictions for clinical use,” Interdisciplinary Perspectives on Infectious Diseases, vol. 2012, Article ID 976273, 37 pages, 2012. View at Publisher · View at Google Scholar
  30. G. Bonkat, G. Müller, O. Braissant et al., “Increasing prevalence of ciprofloxacin resistance in extended-spectrum-β-lactamase-producing Escherichia coli urinary isolates,” World Journal of Urology, vol. 31, no. 6, pp. 1427–1432, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Charalabopoulos, G. Karachalios, D. Baltogiannis, A. Charalabopoulos, X. Giannakopoulos, and N. Sofikitis, “Penetration of antimicrobial agents into the prostate,” Chemotherapy, vol. 49, no. 6, pp. 269–279, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. J. A. Goldman and G. L. Kearns, Fluoroquinolone Use in Paediatrics: Focus on Safety and Place in Therapy, World Health Organization, Geneva, Switzerland, 2011.